“The system has the great advantage that it can support both ventricles and it generates very high flows. That means it´s basically better in performance than what we always do with implantable systems, that only support the left ventricle.”

The access to some or all shown products may be restricted by country-specific regulatory approvals. The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft, Excor mobile and EXCOR® Active is not FDA approved and not available for commercial use in the US. 

Subtitles: Youtube